>>> SAnofi CVR -65% in pre market in the US @ $0.75 Sanofi Multiple Sclerosis Drug May Be Too Risky, FDA Staff Says {NSN MVY4GB6TTDTP <go>} {GCVRZ US Equity DES<GO>}